Xiangrui Han
Hiroshima, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
LX1 Dual Targets AR Variants and AKR1C3 in Advanced Prostate Cancer Therapy.
Journal: Cancer research
Published: February 05, 2024
Microtubule-associated protein tau (MAPT) promotes bicalutamide resistance and is associated with survival in prostate cancer.
Journal: Urologic oncology
Published: April 09, 2020
PTEN Is Involved in Sunitinib and Sorafenib Resistance in Renal Cell Carcinoma.
Journal: Anticancer research
Published: February 11, 2020
TUBB3 Is Associated with High-Grade Histology, Poor Prognosis, p53 Expression, and Cancer Stem Cell Markers in Clear Cell Renal Cell Carcinoma.
Journal: Oncology
Published: January 21, 2020
Microtubule-associated protein tau (MAPT) is a promising independent prognostic marker and tumor suppressive protein in clear cell renal cell carcinoma.
Journal: Urologic oncology
Published: December 27, 2019
TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer.
Journal: International journal of molecular sciences
Published: July 22, 2019
Magnetic resonance imaging/transrectal ultrasonography fusion targeted prostate biopsy finds more significant prostate cancer in biopsy-naïve Japanese men compared with the standard biopsy.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: April 08, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026